{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:10:19Z","timestamp":1761520219570,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002467","name":"Dankook University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002467","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.clcc.2020.04.001","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T20:19:57Z","timestamp":1586809197000},"page":"e75-e82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Survival Outcomes After Initial Treatment for Anal Adenocarcinoma: A Population-Based Cohort Study"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7361-4455","authenticated-orcid":false,"given":"Hyojung","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2020.04.001_bib1","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s10350-004-6740-9","article-title":"Primary adenocarcinoma of the anus treated with combined modality therapy","volume":"46","author":"Beal","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2020.04.001_bib2","first-page":"47","article-title":"Comparative survival of patients with anal adenocarcinoma, squamous cell carcinoma of the anus, and rectal adenocarcinoma","volume":"15","author":"Franklin","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2020.04.001_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1177\/000313481508101122","article-title":"Anal adenocarcinoma: outcomes in an uncommon malignancy","volume":"81","author":"Bertelson","year":"2015","journal-title":"Am Surg"},{"key":"10.1016\/j.clcc.2020.04.001_bib4","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1245\/s10434-019-07202-4","article-title":"Survival outcomes and patterns of management for anal adenocarcinoma","volume":"26","author":"Lewis","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2020.04.001_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0360-3016(02)04118-4","article-title":"Chemoradiation for adenocarcinoma of the anus","volume":"55","author":"Papagikos","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2020.04.001_bib6","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1245\/s10434-009-0392-x","article-title":"Abdominal perineal resection improves survival for nonmetastatic adenocarcinoma of the anal canal","volume":"16","author":"Kounalakis","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2020.04.001_bib7","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/codi.12325","article-title":"Adenocarcinoma of the anal canal\u2014a systematic review","volume":"15","author":"Anwar","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.clcc.2020.04.001_bib8","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0360-3016(03)00277-3","article-title":"Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network","volume":"56","author":"Belkacemi","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2020.04.001_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2020.04.001_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/vco.12022","article-title":"Comparison of abdominal ultrasound and magnetic resonance imaging for detection of abdominal lymphadenopathy in dogs with metastatic apocrine gland adenocarcinoma of the anal sac","volume":"13","author":"Anderson","year":"2015","journal-title":"Vet Comp Oncol"},{"key":"10.1016\/j.clcc.2020.04.001_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0002-9610(99)80143-3","article-title":"Prognosis and recurrence patterns of anal adenocarcinoma","volume":"169","author":"Basik","year":"1995","journal-title":"Am J Surg"},{"key":"10.1016\/j.clcc.2020.04.001_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0360-3016(99)00267-9","article-title":"Primary adenocarcinoma of the anus: a retrospective analysis","volume":"45","author":"Joon","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2020.04.001_bib13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/DCR.0b013e3181a79589","article-title":"A\u00a0twenty-year experience with adenocarcinoma of the anal canal","volume":"52","author":"Chang","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2020.04.001_bib14","first-page":"1097","article-title":"Anal adenocarcinoma requires prophylactic inguinal nodal treatment: results from a single Chinese institution","volume":"8","author":"Su","year":"2017","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.clcc.2020.04.001_bib15","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1002\/cam4.2076","article-title":"Anal adenocarcinoma: treatment outcomes and trends in a rare disease entity","volume":"8","author":"Wegner","year":"2019","journal-title":"Cancer Med"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002820300475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002820300475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:06:51Z","timestamp":1761520011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002820300475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1533002820300475"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2020.04.001","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival Outcomes After Initial Treatment for Anal Adenocarcinoma: A Population-Based Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2020.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}